You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
騰訊(00700.HK)向兩肺炎醫藥研究團隊免費開放騰訊雲超算能力
阿思達克 01-30 16:07

騰訊(00700.HK)宣布,向北京生命科學研究所/清華大學生物醫學交叉研究院的黃牛教授實驗室,以及中山大學藥學院的羅海彬教授團隊提供免費的騰訊雲超算能力、運算集群支持以及基礎的雲計算能力,以應付冠肺炎的藥物篩選和病毒突變預測工作。

騰訊雲目前已向中山大學藥學院羅海彬教授團隊提供了批量GPU雲服務器免費使用權,以幫助該團隊推進病毒藥物的篩選工作。同時,騰訊雲也向北京生命科學研究所/清華大學生物醫學交叉研究院的黃牛教授實驗室提供大量標準CPU算力以及對象儲存能力,以進行基因測算的離線計算任務。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account